What is Brief History of Leidos Company?

GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Leidos

Full Company Analysis:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

What is the history of Leidos?

In 2024, Leidos, a global science and technology solutions company, reported impressive annual revenues of $16.7 billion, solidifying its position as a Fortune 500 leader in the defense, intelligence, civil, and health sectors.

What is Brief History of Leidos Company?

This formidable market presence stands in stark contrast to its humble beginnings in 1969. The company's journey began with a pivotal moment when Dr. J. Robert Beyster, a nuclear physicist, founded Science Applications Incorporated (SAI) in La Jolla, California, with an initial vision to apply scientific principles to solve complex problems.

Leidos' core capabilities today include digital modernization, engineering, and advanced analytics, addressing critical challenges for government and commercial customers worldwide. Its focus on areas like cybersecurity, artificial intelligence, and mission-critical systems highlights a continuous evolution from its foundational scientific research. With a workforce of approximately 48,000 global employees as of January 2025, Leidos is committed to making the world safer, healthier, and more efficient through technology. This article will explore the company's significant journey, from its founding as a 'crazy little company' to its present-day status as a major global player, detailing its growth, key innovations, and future outlook. For a deeper dive into its strategic positioning, consider exploring the Leidos BCG Matrix.

What is the Leidos Founding Story?

The Leidos company background traces back to February 3, 1969, when Dr. J. Robert Beyster, a nuclear physicist, established Science Applications Incorporated (SAI) in La Jolla, California. Dr. Beyster envisioned a research-focused enterprise that fostered a productive environment for scientists and engineers to tackle significant national challenges.

Icon

The Genesis of Leidos

Dr. J. Robert Beyster, a seasoned physicist, founded Science Applications Incorporated (SAI) with a vision for a different kind of company. His aim was to create a workplace where talented individuals could thrive while addressing critical national issues.

  • Founded on February 3, 1969, by Dr. J. Robert Beyster.
  • Initial investment was $50,000 of personal funds, with a home used as collateral for a bank loan.
  • Dr. Beyster deferred his own salary in the first year to prioritize employee compensation.
  • The company's early business model emphasized employee ownership as a key strategy for recruitment and retention.
  • Employees were encouraged to participate in management and sales, acting as frontline representatives.
  • The U.S. government was the inaugural customer, engaging SAI for nuclear weapon effects analysis.
  • SAI achieved profitability in its first year of operation.
  • The name 'Science Applications Incorporated' was chosen for its broad applicability without being overly ambitious.
  • This foundational period set the stage for the Revenue Streams & Business Model of Leidos that would develop over time.

Complete Leidos Strategy Bundle

  • 6 Full Frameworks, 1 Company – All Pre-Researched
  • Each Framework Fully Sourced with Real Company Data
  • Built for Strategy Courses, Case Studies & MBA Programs
  • Adapt to Your Assignment – No Starting from Scratch
  • 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
Get Related Template

What Drove the Early Growth of Leidos?

The early years of Science Applications Incorporated (SAI) saw rapid growth and diversification, laying the groundwork for its future expansion. The company quickly established its presence in critical scientific and defense sectors, marking the beginning of its extensive Leidos history.

Icon Early Health Sector Involvement

In 1970, SAI secured a contract with Los Alamos National Laboratory to study radiation-based cancer therapy. This project was instrumental in establishing the company's health business, a key area in its Leidos company background.

Icon Geographic and Technical Expansion

By 1972, SAI opened an office in Albuquerque to support the Air Force Weapons Laboratory. This expansion focused on electromagnetic phenomena and effects, forming the basis of its Physical Science Group and contributing to its Leidos evolution.

Icon International Reach and Disaster Response

SAI's global footprint expanded in 1976 with its first major international contract for the Kuwaiti Defense Forces. The company also played a significant role in the cleanup operations following the Three Mile Island nuclear incident.

Icon Major Contract Wins and Public Offering

As SAIC, the company secured its first billion-dollar contract in 1988 for the Department of Defense's Composite Health Care System. In 2006, SAIC transitioned to a publicly traded company, marking a significant step in its Leidos timeline and corporate journey.

Icon Strategic Relocation and Growth

The company's headquarters moved from San Diego to McLean, Virginia, to better align with its federal contracting focus. By 2012, SAIC had grown into an impressive enterprise with nearly 40,000 employees and revenues of approximately $11 billion.

Icon The Formation of Leidos

In 2013, SAIC underwent a significant split, creating two independent companies. The entity focused on national security, health, and engineering solutions was rebranded as Leidos Holdings Inc., headquartered in Reston, Virginia, enabling it to pursue new opportunities and contracts previously restricted by conflict rules. This strategic move was a pivotal moment in the Growth Strategy of Leidos.

From PESTLE Factors to Full Strategy Bundle

  • PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
  • Every Strategic Angle Covered – Nothing Left to Research
  • Pre-filled with Company-Specific Research
  • No Missing Sections for Your Case Study
  • One Download Covers Your Entire Company Analysis
Get Related Template

What are the key Milestones in Leidos history?

Leidos, as the legal successor to SAIC, has marked a significant journey with numerous milestones and innovations. Its origins trace back to the foundational work of SAIC, and since its inception as Leidos, the company has demonstrated a consistent drive for technological advancement and strategic growth. This Brief History of Leidos highlights key moments in its evolution.

Year Milestone
1987 Recognized for contributions to the design of the America's Cup boat, Stars and Stripes.
(Prior to 2013) Developed and deployed the Department of Defense's Composite Health Care System to over 500 facilities worldwide.
(Recent Years) Successfully completed the deployment of MHS GENESIS, the world's largest electronic health record system.
2024 Successfully tested its Enduring Shield system, intercepting unmanned aircraft systems and cruise missile targets for the U.S. Army.
2025 Awarded a potential $89 billion contract for the Frederick National Laboratory for Cancer Research.

Leidos has consistently pushed the boundaries of innovation, particularly in the healthcare and defense sectors. The company's development and deployment of the Department of Defense's Composite Health Care System was a monumental undertaking, and more recently, the successful implementation of MHS GENESIS, the world's largest electronic health record system, underscores its commitment to advancing health IT infrastructure. Furthermore, the 2024 test of the Enduring Shield system demonstrates its cutting-edge capabilities in national security solutions.

Icon

Composite Health Care System

Developed and deployed the Department of Defense's Composite Health Care System to over 500 facilities worldwide.

Icon

MHS GENESIS Deployment

Successfully completed the deployment of MHS GENESIS, the world's largest electronic health record system, serving over 9.5 million beneficiaries.

Icon

Enduring Shield System Test

Achieved a technological breakthrough with the successful test of its Enduring Shield system for the U.S. Army in 2024.

Icon

Frederick National Laboratory Contract

Secured a potential $89 billion contract for the Frederick National Laboratory for Cancer Research, a testament to its enduring capabilities.

The company has navigated significant challenges throughout its history, including a substantial financial penalty in 2012 for overbilling. The strategic decision to split into Leidos and a new SAIC in 2013 was a direct response to address organizational conflicts of interest and broaden market opportunities. More recently, Leidos faced external pressures, including being placed on China's export control list in March 2025 and the termination of a $2.4 billion cybersecurity services contract by the Department of Homeland Security in May 2025.

Icon

Overbilling Fine

In 2012, SAIC was ordered to pay $550 million to New York City for overbilling on a contract.

Icon

Strategic Split

The 2013 split aimed to eliminate perceived organizational conflicts of interest, allowing both entities to pursue diverse contracts.

Icon

Export Control List

On March 4, 2025, the Chinese Ministry of Commerce added Leidos to its export control list, restricting dual-use commodity exports.

Icon

Contract Termination

In May 2025, the Department of Homeland Security terminated its $2.4 billion cybersecurity services contract with Leidos for convenience.

Leidos Business Model + Strategy Bundle

  • Ideal for Essays, Case Studies & Slides
  • Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
  • Company-Specific Content Already Organized
  • One Bundle Replaces Days of Independent Research
  • Buy the Bundle Once. Use Across All Your Assignments
Get Related Template

What is the Timeline of Key Events for Leidos?

The Leidos company history is a fascinating journey from a small scientific consultancy to a major government contractor. Tracing the Leidos origins reveals a commitment to applying science and technology to solve complex challenges.

Year Key Event
1969 Dr. J. Robert Beyster founded Science Applications Incorporated (SAI) in La Jolla, California.
1970 SAI began its health business by winning a contract for radiation-based cancer therapy.
1976 SAI secured its first significant international contract with the Kuwaiti Defense Forces.
1984 Science Applications Incorporated (SAI) was renamed Science Applications International Corporation (SAIC).
1988 SAIC was awarded its first billion-dollar contract for the Department of Defense's Composite Health Care System.
2006 SAIC transitioned from employee ownership to a publicly traded company.
2013 SAIC split into two entities: Leidos Holdings Inc. and a new SAIC, with Leidos relocating its headquarters to Reston, Virginia.
2016 Leidos merged with Lockheed Martin's Information Systems & Global Solutions (IS&GS) business for approximately $4.6 billion.
2020 Leidos acquired defense contractor Dynetics for approximately $1.65 billion and L3Harris Technologies' Security Detection and Automation businesses for about $1 billion.
2024 Leidos completed the deployment of MHS GENESIS, the world's largest electronic health record system, and reported annual revenues of $16.7 billion.
2025 Leidos reported Q1 2025 revenues of $4.25 billion and announced a $300 million acquisition in the cyber sector.
Icon Strategic Growth and Financial Strength

Leidos reported revenues of $16.7 billion for fiscal year 2024, an 8% increase year-over-year. The company's backlog stood at $43.6 billion at the end of 2024, indicating strong future revenue potential.

Icon Future Outlook and Strategic Initiatives

For 2025, Leidos forecasts revenues between $16.9 billion and $17.3 billion. The company's 'NorthStar 2030' strategy focuses on government priorities like IT modernization and transformational warfighting capabilities.

Icon Acquisitions and Market Expansion

Recent acquisitions, such as the $300 million deal for a cyber platforms company in May 2025, demonstrate Leidos' commitment to expanding its technological capabilities. This aligns with the Mission, Vision & Core Values of Leidos.

Icon Operational Performance and Investment

The company projects operating cash flow of approximately $1.45 billion for 2025. Leidos' robust bid pipelines and strong backlog provide a solid foundation for continued growth and investment in innovation.

From Five Forces to Full Company Analysis

  • Includes SWOT, PESTLE, BMC, BCG and 4P's
  • Pre-Researched with Company-Specific Data
  • Best Value for a Complete Analysis
  • Ready to Adapt for Your Case Study
  • Ready for Essays and Slidesd
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.